MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC)

Published:2004-03 Issue:3 Volume:43 Page:285-295
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Dworakowska Dorota,Jassem Ewa,Jassem Jacek,Peters Brigitte,Dziadziuszko Rafał,Żylicz Maciej,Jakóbkiewicz-Banecka Joanna,Kobierska-Gulida Grażyna,Szymanowska Amelia,Skokowski Jan,Roessner Albert,Schneider-Stock Regine

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Global cancer statistics;Parkin;CA Cancer J. Clin.,1999

2. Results of surgical treatment of non-small cell lung cancer: validation of the new postsurgical pathological TNM classification;Jassem;J. Thorac. Cardiovasc. Surg.,2000

3. Mdm2 oncogene as a novel target for human cancer therapy;Zhang;Curr. Pharm. Des.,2000

4. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line;Fakharzadeh;EMBO J.,1991

5. The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation;Momand;Cell,1992

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDM2 stabilization of Notch intracellular domain upon DNA damage plays a major role in non-small cell lung carcinoma response to platinum chemotherapy;2024-05-01

2. MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future;Pharmacological Reviews;2024-03-15

3. E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities;Life Sciences;2024-01

4. Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy;Life Sciences;2023-08

5. Amivantamab: A New Hope in Targeting Non-small Cell Lung Cancer;Anti-Cancer Agents in Medicinal Chemistry;2023-01